Dewpoint Therapeutics congratulates Scientific founder Anthony Hyman on receiving the 2021 HFSP Nakasone Award from The Human Frontier Science Program […]

BOSTON, October 13, 2020 —  Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Ameet Nathwani, M.D., as Chief Executive […]

The announcement of Dewpoint Therapeutics successful $77 million Series B raise has received significant attention in from both Industry and […]

BOSTON, September 29, 2020 – Dewpoint Therapeutics, the biomolecular condensates company, today announced it has raised $77 million in a Series B […]

We are proud to have been featured by Business Insider as one of 21 start-ups considered by top biotech venture […]

BOSTON, July 13, 2020  —  Dewpoint Therapeutics, the biomolecular condensates company, announced today that it has forged an exclusive collaboration agreement with Merck, known as […]

BOSTON, June 17, 2020 –  Dewpoint Therapeutics, the biomolecular condensates company, has announced the appointments of Olivier Brandicourt and Jürgen Eckhardt to […]

Dewpoint congratulates its co-founder, Tony Hyman, who was this week elected to the National Academy of Sciences in honor of his […]

Dewpoint congratulates its co-founder Tony Hyman, for receiving the NOMIS Foundation’s Distinguished Scientist and Scholar Award.  The award recognises outstanding contributions […]

Dewpoint Therapeutics co-founder Anthony Hyman will share the 2020 Wiley Prize in Biomedical Sciences for his foundational work on biomolecular […]